Despite the contributions of more than 700,000 men to randomized controlled trials (RCTs) of prostate cancer (PC) screening over several decades, it is still unclear whether there is a PC-specific ...
Data science leader to advance Valo’s leading human causal biology platform for drug discovery Valo Health, Inc. (“Valo”), a pioneer in the use of human data and AI to accelerate drug discovery and ...
View all available purchase options and get full access to this article. The following represents disclosure information provided by authors of this manuscript. All relationships are considered ...
LEXINGTON, Mass., April 14, 2026--(BUSINESS WIRE)--Valo Health, Inc. ("Valo"), a pioneer in the use of human data and AI to accelerate drug discovery and development, today announced the appointment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results